A Fixed-sequence, Open-label Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 26 Dec 2017
At a glance
- Drugs Esketamine (Primary) ; Ticlopidine
- Indications Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 18 Dec 2017 Status changed from active, no longer recruiting to completed.
- 17 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 17 Oct 2017 Status changed from not yet recruiting to recruiting.